Mon Aug 10 72 patient multi-indication trial approved to fast track TRP-8803 commercialisation Written by PR Newswire Asia - News Pronto RSS Enable JavaScript and cookies to continueRead more http://www.prnasia.com/story/archive/5018483_CN18483_0
